etoposide has been researched along with Cancer Syndromes, Hereditary in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hutchinson, RJ; Rubin, MA; Shulkin, BL; Snyder, KM; Wechsler, DS | 1 |
| Antoneli, CB; Arias, VE; Chojniak, MM; Novaes, PE; Ribeiro, Kde C; Sakamoto, LH | 1 |
| Martin, PL; McLean, TW; White, MS | 1 |
| Bieth, E; Brennetot, C; Hofman, P; Pedeutour, F; Rouzier, C; Soler, C | 1 |
2 review(s) available for etoposide and Cancer Syndromes, Hereditary
| Article | Year |
|---|---|
Trilateral retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disease Progression; Etoposide; Eye Enucleation; Eye Neoplasms; Fatal Outcome; Female; Humans; Idarubicin; Ifosfamide; Male; Methotrexate; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Neoplastic Syndromes, Hereditary; Pinealoma; Prognosis; Retinoblastoma; Vincristine | 2007 |
Ovarian dysgerminoma and Apert syndrome.
Topics: Acrocephalosyndactylia; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chromosome Aberrations; Combined Modality Therapy; Dysgerminoma; Etoposide; Female; Humans; In Situ Hybridization, Fluorescence; Neoplasm Proteins; Neoplastic Syndromes, Hereditary; Nucleic Acid Hybridization; Ovarian Neoplasms; Ovariectomy; Point Mutation; Receptor, Fibroblast Growth Factor, Type 2; Remission Induction | 2008 |
2 other study(ies) available for etoposide and Cancer Syndromes, Hereditary
| Article | Year |
|---|---|
Mediastinal seminoma in a patient with Wiskott-Aldrich syndrome.
Topics: Adolescent; Anaphylaxis; Anemia, Hemolytic, Autoimmune; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Etoposide; Gallium Radioisotopes; Granulocyte Colony-Stimulating Factor; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Mediastinal Neoplasms; Neoplastic Syndromes, Hereditary; Prednisone; Radionuclide Imaging; Radiopharmaceuticals; Remission Induction; Seminoma; Vincristine; Wiskott-Aldrich Syndrome | 2002 |
Acute myelogenous leukemia associated with Ollier disease.
Topics: Aminoglycosides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 21; Cytarabine; Daunorubicin; Enchondromatosis; Etoposide; Gemtuzumab; Graft vs Host Disease; Humans; Infant; Leukemia, Myeloid, Acute; Male; Mitoxantrone; Neoplastic Syndromes, Hereditary; Translocation, Genetic | 2008 |